Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis -: art. no. 98

被引:142
作者
Ekberg-Aronsson, M [1 ]
Pehrsson, K
Nilsson, JÅ
Nilsson, PM
Löfdahl, CG
机构
[1] Lund Univ, Dept Resp Med & Allergol, S-22185 Lund, Sweden
[2] Lund Univ, Univ Hosp, Dept Med, S-20502 Malmo, Sweden
关键词
D O I
10.1186/1465-9921-6-98
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: The GOLD classification of COPD severity introduces a stage 0 ( at risk) comprising individuals with productive cough and normal lung function. The aims of this study were to investigate total mortality risks in GOLD stages 0 - 4 with special focus on stage 0, and furthermore to assess the influence of symptoms of chronic bronchitis on mortality risks in GOLD stages 1 - 4. Method: Between 1974 and 1992, a total of 22 044 middle-aged individuals participated in a health screening, which included a spirometry as well as recording of respiratory symptoms and smoking habits. Individuals with comorbidity at baseline ( diabetes, stroke, cancer, angina pectoris, or heart infarction) were excluded from the analyses. Hazard ratios (HR 95% CI) of total mortality were analyzed in GOLD stages 0 - 4 with individuals with normal lung function and without symptoms of chronic bronchitis as a reference group. HR: s in smoking individuals with symptoms of chronic bronchitis within the stages 1 - 4 were calculated with individuals with the same GOLD stage but without symptoms of chronic bronchitis as reference. Results: The number of deaths was 3674 for men and 832 for women based on 352 324 and 150 050 person-years respectively. The proportion of smokers among men was 50% and among women 40%. Self reported comorbidity was present in 4.6% of the men and 6.6% of the women. Among smoking men, Stage 0 was associated with an increased mortality risk, HR; 1.65 ( 1.32 - 2.08), of similar magnitude as in stage 2, HR; 1.41 ( 1.31 - 1.70). The hazard ratio in stage 0 was significantly higher than in stage 1 HR; 1.13 ( 0.98 - 1.29). Among male smokers with stage 1; HR: 2.04 ( 1.34 - 3.11), and among female smokers with stage 2 disease; HR: 3.16 ( 1.38 - 7.23), increased HR: s were found in individuals with symptoms of chronic bronchitis as compared to those without symptoms of chronic bronchitis. Conclusion: Symptoms fulfilling the definition of chronic bronchitis were associated with an increased mortality risk among male smokers with normal pulmonary function ( stage 0) and also with an increased risk of death among smoking individuals with mild to moderate COPD ( stage 1 and 2).
引用
收藏
页数:9
相关论文
共 26 条
[1]  
ANNESI I, 1986, AM REV RESPIR DIS, V134, P688
[2]   Long-term outcome of the Malmo Preventive Project:: mortality and cardiovascular morbidity [J].
Berglund, G ;
Nilsson, P ;
Eriksson, KF ;
Nilsson, JÅ ;
Hedblad, B ;
Kristenson, H ;
Lingärde, F .
JOURNAL OF INTERNAL MEDICINE, 2000, 247 (01) :19-29
[3]   Cardiovascular risk groups and mortality in an urban Swedish male population: The Malmo Preventive Project [J].
Berglund, G ;
Eriksson, KF ;
Israelsson, B ;
Kjellstrom, T ;
Lindgarde, F ;
Mattiasson, I ;
Nilsson, JA ;
Stavenow, L .
JOURNAL OF INTERNAL MEDICINE, 1996, 239 (06) :489-497
[4]   Is calculating pack-years retrospectively a valid method to estimate life-time tobacco smoking? A comparison between prospectively calculated pack-years and retrospectively calculated pack-years [J].
Bernaards, CM ;
Twisk, JWR ;
Snel, J ;
Van Mechelen, W ;
Kemper, HCG .
ADDICTION, 2001, 96 (11) :1653-1661
[5]   The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease [J].
Celli, BR ;
Cote, CG ;
Marin, JM ;
Casanova, C ;
de Oca, MM ;
Mendez, RA ;
Pinto Plata, V ;
Cabral, HJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (10) :1005-1012
[6]  
COX DR, 1972, J R STAT SOC B, V34, P187
[7]   Lung function, insulin resistance and incidence of cardiovascular disease:: a longitudinal cohort study [J].
Engström, G ;
Hedblad, B ;
Nilsson, P ;
Wollmer, P ;
Berglund, G ;
Janzon, L .
JOURNAL OF INTERNAL MEDICINE, 2003, 253 (05) :574-581
[8]   NATURAL-HISTORY OF CHRONIC AIR-FLOW OBSTRUCTION [J].
FLETCHER, C ;
PETO, R .
BMJ-BRITISH MEDICAL JOURNAL, 1977, 1 (6077) :1645-1648
[9]  
Hole DJ, 1996, BRIT MED J, V313, P711
[10]  
Hurd S, 2000, CHEST, V117, P1